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Abstract
Introduction: Signet-ring cell carcinoma is a rare and aggressive variant of mucinous adenocarcinoma. Only a few
cases of gallbladder adenocarcinoma with signet-ring cells have been reported and because of this there is a lack
of knowledge about the behavior and biology of this pathology.
Case presentation: We present the case of a 63-year-old Arab man with gallbladder signet-ring cell
adenocarcinoma. He had an elective cholecystectomy and refused chemotherapy. Two months later, a small
hepatic metastatic nodule was found, and nine months later he presented with multiple metastases in the liver,
lymphatic nodes, both pleuras, peritoneum and subcutaneous tissue.
Conclusion: The proliferation of signet-ring cells in a gallbladder adenocarcinoma worsens the prognosis of an
already adverse neoplasm. New lines of treatment in chemotherapy, such as cisplatin, or new biological therapy,
such as monoclonal antibody c-myc oncogene, should be encouraged to improve the survival and life quality of
these oncologic patients.
Introduction
Gallbladder carcinoma (GC) is the fifth most common
malignant tumor of the gastrointestinal tract and the
most frequent malignant neoplasm of the biliary tract [1].
Approximately 99% of gallbladder cancers are carcino-
mas including 90% of adenocarcinomas, mostly well or
moderately differentiated (74%). Five percent of gallblad-
der carcinomas comprise other subtypes such as papil-
lary adenocarcinomas, squamous cell carcinomas and
mucinous adenocarcinomas [1].
Signet-ring cell carcinoma (SRCC) is a rare and
aggressive variant of mucinous adenocarcinoma. It is
histologically characterized by the presence of rounded
cells with a clear and mucinous cytoplasm and a periph-
eral nucleus. Its aggressive behavior is shown by the
infiltration of the surrounding stroma, broad dissemina-
tion and a high tendency to produce peritoneal metas-
tases in the gastrointestinal tract, as in our patient [2].
The presence of non-neoplastic signet-ring cells on
normal tissues is a source of pitfalls in biopsy specimens
that leads to over-diagnosis of SRCC. Although the
meaning of this histological finding is still unclear [3],
the features that define this entity are: the confinement
of non-neoplastic cells to the mucosal surface, their lack
of cellular atypia [4] and necrotic changes with sur-
rounding inflammation [5].
GC-related symptoms are nonspecific. The risk factors
have not been determined yet, although a close relation-
ship with gallstones has been described [6]. As a result,
almost one percent of all cholecystectomies have been
reported to contain a malignant neoplasm focus [7].
Case report
A 63-year-old Arab man with symptoms of three-month
duration including a dull epigastric pain radiating to the
right hypochondrium was transferred from a local hos-
pital to our University Hospital. An upper endoscopy
was performed and a mild gastritis (Helicobacter pylori
negative) was diagnosed. The patient received proper
treatment, but the pain persisted. Ultrasonography
revealed many gallstones with thickened wall of the gall
bladder. Images were not available to us because these
examinations were performed before the referral of the
patient.
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omy in our center. According to his medical history he
had frequent episodes of biliary colic and a cholangitis
episode which resolved following endoscopic retrograde
cholangiopancreatography papillotomy (ERCP). He had
a normal cholangioresonance study.
Laparoscopic cholecystectomy revealed an empyema of
the gallbladder with stones which made the dissection
very difficult because of local inflammation. The gallblad-
der was finally removed inside a vinyl extraction bag.
The day after surgery, the patient complained of pain
at the right hypochondrium and a 2 g hemoglobin
decrease was detected. Computed tomography (CT)
showed a perihepatic hematoma extending to the right
paracolic gutter and no suspicious focus of other neo-
plasm was found.
Histology revealed a poorly differentiated adenocarci-
noma with signet-ring cells (SRCC) extending to the
surrounding connective tissue, as well as to the micro-
vasculature and invasion of the cystic duct surgical mar-
gins (Figure 1). Immunohistochemical staining showed
p53 mutation and CK7 were positive; results for CK20
and estrogen were negative. He was histologically classi-
fied as a grade 3 (poorly differentiated) with a T2NxMx
stage. After his recovery, a radical resection and che-
motherapy was proposed, but he rejected this treatment
for personal reasons.
Several CTs and ultrasound scans were performed as
follow up of the hematoma, and no images of wide-
spread disease or other complications were found until
seven weeks after surgery, when a CT revealed a 19 mm
hypodense nodule on the VIII liver segment. We per-
formed a fine needle aspiration (FNA) to evaluate this
nodule. It was shown on cytology to be a metastatic
SRCC. After a new evaluation, the patient rejected che-
motherapy again.
Nine months later, he presented with jaundice and pain
in the right hypochondrium. A new CT showed right
pleural effusion with nodular lesions on both pleuras, ret-
roperitoneal and right axillary adenopathies, liver masses,
peritoneal dissemination and subcutaneous nodules on
the chest wall and, at the entrance of the right laparo-
scopy trocar, that were described as metastases (Figure
2). The patient was placed on a palliative care program
which lasted for one month until his death.
Discussion
Gallbladder carcinoma is the fifth most common malig-
nant neoplasm of the digestive tract, adenocarcinoma
being the most frequent histological type [2]. The pre-
sence of signet-ring cell proliferation accounts for a
highly aggressive pathology, with only a few cases
reported [8].
SRCC can arise from virtually any organ but most
are from the stomach, breast, and colon [3,9]. Regard-
less of the tissue origin, SRCCs frequently metastasize
to peritoneal surfaces, regional lymph nodes, ovaries
and lungs [9].
Immunohistochemical staining is useful to determine
the origin and malignant potential of the signet-ring
cells. Gastric SRCC is positive for CK7, CK20 and
MUC2 and negative for MUC1. Breast SRCC are mostly
CK7-, MUC1-and estrogen-positive and CK20-negative.
Colon SRCC are usually CK20- and MUC2-positive and
CK7- and MUC1-negative [9-11]. Non-neoplastic signet-
ring cells exhibit E-cadherin but no p53 mutation [5]. In
our case, immunohistochemical staining of the neoplasm
showed p53 mutation and CK7 positive results, with
CK20 and estrogen negative results, thus confirming its
malignancy and ruling out breast, colon and stomach as
the SRCC origin. Therefore, the consistent histological
findings (Diastase-PAS), immunohistochemical staining
(eliminating the most common primary SRCC neo-
plasms: stomach, breast and colon) and in the absence
of other primary neoplasms in the imagining studies,
the patient was diagnosed with gallbladder SRCC.
Figure 1 A: Poorly differentiated gallbladder adenocarcinoma with signet-ring cells (Hematoxylin- eosin, original magnification ×20).
B: High power magnification and inset: Signet-ring cell with cytoplasmatic vacuole of mucinous material. (Diastase-PAS stain).
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radiological studies are the first steps in the diagnosis of
possible metastatic SRCC, even before conducting
immunohistochemical studies. In the case of our patient,
clinical data, histology, radiology and an extensive
autopsy ruled out the possibility of metastasis and non-
neoplastic signet-ring cell changes.
As long as GC is known as an aggressive neoplasm,
early detection and radical surgery are the best treat-
ments. According to several series, such as those pub-
lished by Kondo [12] in Japan and Dixon [13] in the US,
radical surgery was proven to increase the survival rate
of GC patients, becoming the most appropriate surgical
option whenever possible.
Survival and prognosis of GC patients are improved by
an early diagnosis; unfortunately its clinical characteris-
tics appear at an advanced stage, so the more character-
istics that are observed the poorer the prognosis. About
one percent of all laparoscopic cholecystectomies pre-
sent a focus of GC as an incidental finding [6].
It has been reported that the most important factor in
determining the increase of survival in these patients is
a negative surgical margin [13]; on the other hand, an
intra-operative perforation of the gallbladder decreases
survival [14]. Surgical dissemination appears to be a risk
factor for peritoneal metastases. Therefore when a gall-
bladder carcinoma is suspected, a vinyl bag is used to
wrap the specimen and prevent its spread. Dissemina-
tion by trocars used in the laparoscopy has been sus-
pected, because they can spread cells through the
abdominal wall entrance when they are removed, but
this hypothesis is still questionable [15].
Although the procedure mentioned above were fol-
lowed during the surgery of this patient, it is necessary
to highlight the infiltrative behavior of this subtype of
neoplasm (SRCC) with frequent local and distant
metastases.
Tetsyri reported a case of SRCC which over-expressed
c-myc oncogene and reported that a specific monoclonal
antibody with reactivity against gallbladder is being stu-
died [16]. Karabulut has alsor e p o r t e dt h a ts i g n e t - r i n g
cells resemble the histology seen in the stomach SRCC
and that chemotherapies such as cisplatin could be use-
ful [8]. This is also reported by Shikata, who achieved
significant positive results [17].
Conclusion
The determination of the neoplastic or non-neoplastic
origin of signet-ring cells is required to determine
whether to start treatment. It is also important to
Figure 2 CT images. A) Hepatic metastasis (red arrow). B) Peritoneal metastases (red arrow). C) Liver infiltration, hilum adenopathies, and
subcutaneous nodule at the entrance of the right laparoscopy trocar (red arrow). D) Nodular metastases in left pleura (red arrow) and right
pleural effusion.
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optimize treatment.
The proliferation of signet-ring cells in gallbladder
adenocarcinoma worsens the patient’s prognosis. With
only a few cases reported and an apparently ineffective
classic line of treatment, we believe that more research
about the biology of this cell line should be encouraged
in order to modify the chemotherapy or to add biologi-
cal therapy.
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